PARK MEDI WORLD LIMITED

10 Dec 2025 - 12 Dec 2025 Individual Category Main Board BSE NSE

Min Investment

₹14904

Price Band

₹154-₹162

Issue Size

₹920.00 Cr

Lot Size

92 (per lot)

IPO Dates
img

10 Dec 2025

Open Date

img

12 Dec 2025

Close Date

img

15 Dec 2025

Allotment Date

img

17 Dec 2025

Listing Date

Know Before Investing

Strengths icon

  • Multi-specialty hospital network with strong presence in the NCR region.
  • Experienced medical professionals and seasoned promoter team.
  • High-end medical infrastructure with advanced diagnostic and treatment facilities.
  • Strong focus on affordable care driving high patient footfall across departments.
  • Expansion underway with capacity enhancement at key hospitals to support future growth.

Weaknesses icon

  • High dependence on key doctors and specialists for patient inflow and revenue.
  • Regulatory risks due to strict compliance requirements in the healthcare sector.
  • Significant working capital and capex needs may strain cash flows over time.
  • Strong competition from established hospital chains and local players in operating regions.
  • Any clinical negligence or service-quality issues could severely damage reputation and revenue.

About Park Medi World Limited

Park Medi World is the second largest private hospital chain in North India with a capacity of 3,000 beds and the largest in Haryana with 1,600 beds as of March 31, 2025. The company operates 14 NABH-accredited multi-super speciality hospitals under the Park brand, with eight also NABL-accredited. Its hospitals across Haryana, Delhi, Punjab and Rajasthan offer 30+ specialties such as neurology, gastroenterology, orthopedics, oncology and critical care, supported by a team of 1,014 doctors and 2,142 nurses. Park Medi World follows a cluster-based growth model that drives operational efficiency, strong patient delivery, and economies of scale. Founded and led by Dr. Ajit Gupta, the chain has grown from a single Delhi clinic in 2000 to a major regional healthcare network through strategic expansions and acquisitions. Bed capacity has increased from 2,550 in FY23 to 3,250 in FY25, with projects under development in Ambala, Panchkula, Rohtak, Gorakhpur and Kanpur, targeting 4,900 beds by March 2028. With advanced ICUs, operating theatres, robotic surgery programs (iMARS), trauma and cancer care facilities, the company is positioned to provide high-quality and affordable healthcare while executing its next phase of growth across North India. Discuss on Trading Q&A

IPO Objectives

1. Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by our Company and certain of our Subsidiaries;

2. Funding capital expenditure for development of new hospital and expansion of existing hospital by our certain Subsidiaries, Park Medicity (NCR) and Blue Heavens, respectively;

3. Funding capital expenditure for purchase of medical equipment by our Company and our certain Subsidiaries, Blue Heavens and Ratangiri; and

4. Unidentified inorganic acquisitions and general corporate purposes.

Company Promoters

Ajit Gupta

Ankit Gupta

Subscription Details

Investor Category Subscription (times)
Qualified Institutions 11.48
Non-Institutional Buyers 15.15
Retail Investors 3.16
Total 29.79
img

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account